期刊文献+

重组人内皮抑素对小鼠肺腺癌LA795的抑制作用 被引量:2

Inhibition of lung adenocarcinoma LA795in mice by recombinant human endostatin
下载PDF
导出
摘要 目的观察重组人内皮抑素(rhES)对小鼠肺腺癌LA795生长和转移的抑制作用。方法对ThES高效表达克隆pCX的表达产物进行纯化,得到ThES。将LA795肺腺癌细胞接种于T739小鼠背部皮下,随机分成2组,接种后第10天起分别给予rhES20mg/kg·b.w.或等体积PBS缓冲液皮下注射,1次/d,共14d。观察2组肿瘤生长情况、肺湿重、肺表面转移结节数、动物生存时间,分别进行t检验。结果治疗前后rhES组肿瘤体积分别为(650±201)mm3、(1642±211)mm3;而PBS组肿瘤体积由治疗前的(623±248)mm3增至(9194±952)mm3。rhES组肺湿重、肺表面转移结节数明显少于PBS组,动物生存时间明显延长(P<0.01)。结论rhES可明显抑制LA795所致的小鼠实验性肿瘤的生长与转移,延长动物的生存时间。 Objective To evaluatetheinhibitoryeffectof recombinanthumanendostatinon tumorgrowthandmetastasisof ade-nocarcinomaLA795inmice.Methods Recombinanthumanendostatinwas purifiedfromendostadin-expressingpCXclones.LA795cellswereinoculatedsubcutaneouslyon thebackof T 739 mice,whichwererandomizedinto2groups.Fromthetenth dayon,treatmentgroupwas given20mg/kgrecombinanthumanendostatinsubcutaneouslydailyfor14consecutivedays,and thecontrolgroupreceivedPBSinthesamemanner.Thesizesof thesubcutaneoustumors,lungweights,thenumberof metas-tasesoverthelungsurfaceandthesurvivaltimeof themicewereobserved.Results Thetumorsizesof thetreatmentgroupin-creasedslowlyfrom(650±201)mm 3 to(1642±21)mm 3 whencomparedwiththoseof thecontrolgroupwhichshowedan in-creasefrom(623±248)mm 3 to(9194±952)mm 3 .Thelungweightof the2groupswas(190±25)mg and(324±43)mg respec-tively,andthenumberof lungsurfacemetastaseswas8±2and22±8foreach.Theaveragesurvivaltimeof theratsinthe2groupswas48d and27d,respectively.Allparametersmeasuredbetweenthe2groupsshowedsignificantdifferences(P<0.01).Con clusion Recombinenthumanendostatinhasstronginhibitoryeffecton boththegrowthof primarytumorandmetastasisof lungadenocarcinomaLA795cells,andprolongsthesurvivaltimeof thetumor-bearingmice.
出处 《第一军医大学学报》 CSCD 北大核心 2001年第12期917-919,F003,共4页 Journal of First Military Medical University
基金 南方医院院长科研基金
关键词 血管生成抑制剂 内皮抑素 肺腺癌 T739小鼠 angiogenesisinhibitor endostatin lungadenocarcinoma T 739 mice
  • 相关文献

参考文献3

  • 1张兆伟 张金芝 等.小鼠肺腺癌(LA-795)细胞株的建立及一些生物学特性的研究[J].中华肿瘤杂志,1985,7(2):83-83.
  • 2Blezinger P,Nature Biotechnol,1999年,17卷,4期,343页
  • 3张兆伟,中华肿瘤杂志,1985年,7卷,2期,83页

共引文献13

同被引文献16

  • 1O'roilly MS, Bochm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumour growth[J]. Cell, 1997, 88(2):277-85.
  • 2Hohenester E, Sasaki T, Olsen BE et al. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution[J]. EMBO J, 1998,17(6): 1656-64.
  • 3Dhanabal M, Ramchandran R, Volk R, et al. Endostatin: yeast production, mutants and antitumor effect in renal cell carcinoma[ J ].Cancer Res, 1999, 59(1): 189-97.
  • 4Boehm T, Folkman J, Browder D, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J].Nature, 1997, 390(6658): 404-7.
  • 5Yokoyama Y, Green JE. Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in transgenic mouse model[J]. Cancer Res, 2000, 60(16): 4362-5.
  • 6Blezinger P, Wan J, Margatet G, et al. Systemic inhibition of tumor growth and tumour metastases by intramuscular administration of the endostatin gene[ J ]. Nature Biotechnol, 1999, 17(4): 343-8.
  • 7Cregg JM, Vedick TS. Recent advances in the expression of foreign genes in Pichia pastoris[ J ]. Biol Technol, 1993, 11 (8): 905-10.
  • 8Folkman J. Tumor angiogenesis:therapeutic implication[J]. N Eng J Med, 1971, 285:1182-6.
  • 9王成伟.血管内皮生长因子与抗血管治疗胶质瘤[J].中国肿瘤临床与康复,1999,6(3):89-90. 被引量:2
  • 10端木建华,庞琦.脑膜瘤抗血管生成治疗进展[J].中国神经精神疾病杂志,2002,28(2):159-160. 被引量:3

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部